Zhenguo Wang Selected Research

Zhenguo Wang Research Topics

Disease

5	COVID-19 06/2022 - 06/2020
5	Inflammation (Inflammations) 12/2019 - 05/2007
4	Neoplasms (Cancer) 08/2020 - 01/2019
2	Critical Illness (Critically Ill) 06/2022 - 08/2021
2	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 01/2021
2	Hypersensitivity (Allergy) 01/2022 - 08/2021
2	Craniocerebral Trauma (Head Injury) 01/2021 - 01/2020
2	Edema (Dropsy) 01/2021 - 09/2017
2	Hepatocellular Carcinoma (Hepatoma) 08/2020 - 01/2020
2	Infections 01/2020 - 05/2008
2	Urinary Bladder Neoplasms (Bladder Cancer) 09/2008 - 08/2006
2	Wounds and Injuries (Trauma) 03/2008 - 10/2006
1	Cholestasis 07/2022
1	Fever (Fevers) 06/2022
1	Disease Progression 06/2022
1	Cough 06/2022
1	Pain (Aches) 05/2022
1	Anemia 01/2022
1	Acute Kidney Injury (Acute Renal Failure) 01/2022
1	Aortic Dissection 01/2022
1	Rhabdomyolysis 01/2022
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2022
1	Respiratory Insufficiency (Respiratory Failure) 08/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Insulin Resistance 01/2021
1	Hypoxia (Hypoxemia) 01/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021
1	Conversion Disorder (Astasia Abasia) 09/2020
1	Type 2 Diabetes Mellitus (MODY) 01/2020
1	Stroke (Strokes) 01/2020
1	Parkinson Disease (Parkinson's Disease) 01/2020
1	Proteinuria 01/2020
1	Brain Injuries (Brain Injury) 01/2020
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2020
1	Ischemia 12/2019
1	Lung Neoplasms (Lung Cancer) 10/2019
1	Liver Neoplasms (Liver Cancer) 09/2019

Drug/Important Bio-Agent (IBA)

5	Pharmaceutical PreparationsIBA 01/2022 - 01/2019
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2008
2	Antiviral Agents (Antivirals)IBA 06/2022 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2020
2	Immunoglobulin E (IgE)IBA 01/2022 - 08/2021
2	Amyloid (Amyloid Fibrils)IBA 01/2022 - 01/2021
2	AntibodiesIBA 08/2021 - 08/2020
2	Biological ProductsIBA 08/2019 - 08/2006
1	XenobioticsIBA 07/2022
1	Viral RNAIBA 06/2022
1	Analgesics (Analgesic Drugs)IBA 05/2022
1	Vinorelbine (Navelbine)FDA LinkGeneric 01/2022
1	Ethanol (Ethyl Alcohol)IBA 01/2022
1	MyoglobinIBA 01/2022
1	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 01/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022
1	Nucleocapsid ProteinsIBA 01/2022
1	Arginine (L-Arginine)FDA Link 01/2022
1	Tryptophan (L-Tryptophan)FDA Link 01/2022
1	Cysteine (L-Cysteine)FDA Link 01/2022
1	SteroidsIBA 01/2022
1	Hormones (Hormone)IBA 01/2022
1	Proline (L-Proline)FDA Link 01/2022
1	Methionine (L-Methionine)FDA Link 01/2022
1	Methylprednisolone FDA LinkGeneric 08/2021
1	oxiracetamIBA 01/2021
1	HMGB1 Protein (HMG1)IBA 01/2021
1	taxifolinIBA 01/2021
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2021
1	PPAR gammaIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 10/2020
1	LithiumIBA 09/2020
1	vanadium pentoxideIBA 09/2020
1	SulfurIBA 09/2020
1	AutoantibodiesIBA 08/2020
1	Carbon MonoxideIBA 06/2020
1	AntioxidantsIBA 01/2020
1	CreatinineIBA 01/2020
1	Long Noncoding RNAIBA 01/2020
1	3-n-butylphthalide (butylphthalide)IBA 01/2020
1	Rosiglitazone (Avandia)FDA Link 01/2020
1	Interferon Type IIBA 01/2020
1	Neuroprotective AgentsIBA 01/2020
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020
1	farnesiferol BIBA 12/2019
1	GTP-Binding Proteins (G-Protein)IBA 12/2019
1	LigandsIBA 12/2019
1	Bile Acids and Salts (Bile Acids)IBA 12/2019
1	Messenger RNA (mRNA)IBA 10/2019
1	Pemetrexed (MTA)FDA Link 10/2019
1	Phosphotransferases (Kinase)IBA 09/2019
1	Sorafenib (BAY 43-9006)FDA Link 09/2019
1	GoldIBA 08/2019
1	hydroxide ionIBA 08/2019
1	AcidsIBA 07/2019
1	EnzymesIBA 07/2019
1	Arachidonic Acid (Vitamin F)IBA 07/2019
1	Docosahexaenoic AcidsIBA 03/2019
1	Eicosapentaenoic AcidIBA 03/2019

Therapy/Procedure

4	Therapeutics 08/2021 - 10/2006
2	Drug Therapy (Chemotherapy) 01/2022 - 01/2019
1	Operative Surgical Procedures 01/2022
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2020